Document is current
Any future updates will be listed below
-
Authors
Hantel, Andrew http://orcid.org/0000-0001-9612-3643
Senay, Emily
Richie, Cristina http://orcid.org/0000-0002-7885-9136
Revette, Anna
Nava-Coulter, Brett http://orcid.org/0009-0001-6341-5137
Hlubocky, Fay J.
Walsh, Thomas P.
Siegler, Mark
Abel, Gregory A.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (K08 CA273043)
Greenwall Foundation (Making-a-Difference Grant, Making-a-Difference Grant, Making-a-Difference Grant, Making-a-Difference Grant, Making-a-Difference Grant)
- License Information
-
More Information
Article History
Received: 16 February 2024
Accepted: 15 August 2024
First Online: 12 September 2024
Competing interests
: A.H. reports receiving personal fees from AbbVie, AstraZeneca, BMS, Celgene and GSK (advisory boards), the American Journal of Managed Care (speaking fee), Genentech and Jazz Pharmaceuticals (consultancy), and Real Chemistry (spousal employment) outside the submitted work. G.A.A. reports receiving personal fees (consultancy) from Novartis outside the submitted work. All other authors declare no competing interests.
